Loading chat...
AL SB239
Bill
AI Summary
-
Repeals Sections 20-2-300 through 20-2-302 of the Alabama Code, known as The Medication Assisted Treatment of Opioid Use Act of 2019.
-
Eliminates the Alabama Board of Medical Examiners' authority to develop and adopt rules governing buprenorphine treatment for opioid addiction in nonresidential settings.
-
Removes the standing working group that was established to assist in drafting the buprenorphine treatment rules.
-
Becomes effective on the first day of the third month following passage and approval by the Governor.
Legislative Description
Relating to Opioid Addiction Treatment; to repeal the Medication Assisted Treatment of Opioid Use Act of 2019, codified as Sections 20-2-300 through 20-2-302, Code of Alabama 1975, that provide for adoption of rules governing use of buprenorphine in the treatment of opioid addiction and a standing working group to assist in drafting the rules.
Medication Assisted Treatment of Opioid Use Act, repealed
Last Action
Enacted
5/18/2023